HK Stock MarketDetailed Quotes
08247 BIOSINO BIO-TEC
- 0.680
- 0.0000.00%
Not Open Oct 15 16:09 CST
98.40MMarket Cap-4625P/E (TTM)
0.000High0.000Low0Volume0.680Open0.680Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)144.71MShares1.24052wk High0.46P/B43.71MFloat Cap0.48052wk Low--Dividend TTM64.29MShs Float6.696Historical High--Dividend LFY0.00%Amplitude0.019Historical Low--Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
BIOSINO BIO-TEC Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -195.12%-17.61M | ---- | 189.00%18.52M | ---- | 197.31%6.41M | ---- | 101.88%2.16M | ---- | -689.21%-114.81M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 2.69%-326K | ---- | -52.97%-335K | ---- | 97.99%-219K | ---- | 5.12%-10.91M | ---- | -1,310.67%-11.5M |
| Attributable subsidiary (profit) loss | ---- | -88.95%-12.35M | ---- | -315.38%-6.53M | ---- | 26.15%-1.57M | ---- | 55.19%-2.13M | ---- | -98.37%-4.75M |
| Impairment and provisions: | ---- | -33.82%3.05M | ---- | -64.56%4.6M | ---- | 349.92%12.99M | ---- | -103.63%-5.2M | ---- | 6,838.43%143.35M |
| -Impairmen of inventory (reversal) | ---- | -52.86%1.75M | ---- | -69.85%3.7M | ---- | 5,507.31%12.28M | ---- | 127.86%219K | ---- | -137.08%-786K |
| -Impairment of trade receivables (reversal) | ---- | 22.06%570K | ---- | --467K | ---- | ---- | ---- | -70.72%356K | ---- | 366.08%1.22M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --309K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 68.28%732K | ---- | 8.21%435K | ---- | 106.96%402K | ---- | -104.04%-5.77M | ---- | 35,363.52%142.92M |
| Asset sale loss (gain): | ---- | 2,188.57%2.4M | ---- | -47.50%105K | ---- | 106.35%200K | ---- | 83.36%-3.15M | ---- | -23,763.75%-18.93M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 86.38%-2.52M | ---- | ---18.52M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 2,188.57%2.4M | ---- | -47.50%105K | ---- | 131.90%200K | ---- | -53.68%-627K | ---- | -610.00%-408K |
| Depreciation and amortization: | ---- | -16.33%20.36M | ---- | -12.89%24.33M | ---- | 10.42%27.93M | ---- | -24.30%25.29M | ---- | 35.12%33.41M |
| -Amortization of intangible assets | ---- | 5.68%2.55M | ---- | 65.59%2.41M | ---- | 19.54%1.46M | ---- | -45.96%1.22M | ---- | 109.87%2.25M |
| Financial expense | ---- | -6.15%6.4M | ---- | -35.48%6.82M | ---- | -6.67%10.57M | ---- | -46.18%11.32M | ---- | 48.46%21.03M |
| Operating profit before the change of operating capital | ---- | -95.96%1.92M | ---- | -15.63%47.5M | ---- | 223.89%56.3M | ---- | -63.64%17.38M | ---- | 105.33%47.8M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -736.01%-16.02M | ---- | 71.19%-1.92M | ---- | 31.12%-6.65M | ---- | -417.46%-9.65M | ---- | 118.89%3.04M |
| Accounts receivable (increase)decrease | ---- | 511.80%35.14M | ---- | -225.10%-8.53M | ---- | -115.75%-2.63M | ---- | 118.80%16.67M | ---- | -374.00%-88.66M |
| Accounts payable increase (decrease) | ---- | -72.75%-29.17M | ---- | -221.77%-16.89M | ---- | 282.19%13.87M | ---- | -109.59%-7.61M | ---- | -7.29%79.35M |
| prepayments (increase)decrease | ---- | -74.65%7.81M | ---- | 437.99%30.81M | ---- | 54.63%-9.12M | ---- | -1,499.16%-20.09M | ---- | 102.38%1.44M |
| Special items for working capital changes | ---- | 53.31%-761K | ---- | -75.65%-1.63M | ---- | -106.33%-928K | ---- | 233.95%14.67M | ---- | -39.32%-10.95M |
| Cash from business operations | ---- | -102.18%-1.08M | ---- | -2.95%49.35M | ---- | 347.61%50.85M | ---- | -64.53%11.36M | ---- | 456.51%32.03M |
| Other taxs | ---- | -12.77%-5.81M | ---- | -93.68%-5.15M | ---- | -836.62%-2.66M | ---- | 67.02%-284K | ---- | 54.25%-861K |
| Interest received - operating | ---- | -2.69%326K | ---- | -52.55%335K | ---- | 137.71%706K | ---- | 60.54%297K | ---- | -69.62%185K |
| Special items of business | -36.08%-28.96M | ---- | -573.16%-21.28M | ---- | -82.26%4.5M | ---- | 372.91%25.35M | ---- | -135.53%-9.29M | ---- |
| Net cash from operations | -36.08%-28.96M | -114.73%-6.56M | -573.16%-21.28M | -8.93%44.53M | -82.26%4.5M | 329.91%48.89M | 372.91%25.35M | -63.72%11.37M | -135.53%-9.29M | 599.49%31.35M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | ---- | -97.94%219K | ---- | -14.04%10.61M | ---- | 795.79%12.34M |
| Loan receivable (increase) decrease | ---- | ---1.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 1.61%378K | ---- | -32.61%372K | ---- | -85.55%552K | ---- | 10.63%3.82M | ---- | 235.57%3.45M |
| Purchase of fixed assets | ---- | -0.09%-16.35M | ---- | -336.41%-16.34M | ---- | 72.80%-3.74M | ---- | -14.08%-13.76M | ---- | 67.86%-12.06M |
| Purchase of intangible assets | ---- | -66.42%-228K | ---- | 95.12%-137K | ---- | -27.66%-2.81M | ---- | 64.66%-2.2M | ---- | -76.50%-6.22M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -142.54%-23.87M | ---- | --56.1M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --24.45M | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -111.21%-15M | ---- | 57.58%-7.1M |
| Other items in the investment business | 65.19%-927K | ---- | -123.85%-2.66M | --14.98M | 601.57%11.17M | ---- | -170.78%-2.23M | ---- | 147.54%3.15M | -76.47%4.82M |
| Net cash from investment operations | 65.19%-927K | -1,484.60%-17.7M | -123.85%-2.66M | 80.67%-1.12M | 601.57%11.17M | 63.76%-5.78M | -170.78%-2.23M | -131.06%-15.94M | 147.54%3.15M | 247.16%51.33M |
| Net cash before financing | -24.82%-29.88M | -155.88%-24.26M | -252.86%-23.94M | 0.69%43.41M | -32.28%15.66M | 1,043.46%43.12M | 476.35%23.13M | -105.53%-4.57M | -131.46%-6.15M | 371.98%82.68M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -9.63%145.87M | ---- | -9.77%161.41M | ---- | -18.15%178.89M | ---- | 28.09%218.54M | ---- | -11.85%170.62M |
| Refund | ---- | 20.78%-144.25M | ---- | 12.83%-182.1M | ---- | -14.19%-208.91M | ---- | 10.86%-182.95M | ---- | -37.05%-205.24M |
| Interest paid - financing | ---- | 12.02%-5.4M | ---- | 41.96%-6.13M | ---- | -1.51%-10.57M | ---- | 27.17%-10.41M | ---- | -0.87%-14.29M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 91.55%-1.13M | ---- | 7.79%-13.34M |
| Absorb investment income | ---- | -21.43%16.5M | ---- | --21M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 13.15%1.55M | ---- | 105.70%1.37M | ---- | 47.49%-24.01M | ---- | -275.44%-45.73M | 59.90%-3.56M | 199.66%26.06M | -387.20%-8.87M |
| Net cash from financing operations | 13.15%1.55M | 195.29%10.25M | 105.70%1.37M | 75.57%-10.76M | 47.49%-24.01M | -314.76%-44.02M | -275.44%-45.73M | 128.82%20.5M | 199.66%26.06M | -423.53%-71.12M |
| Effect of rate | ---- | -67.86%72K | ---- | 387.18%224K | ---- | 85.20%-78K | ---- | -285.56%-527K | ---- | 315.15%284K |
| Net Cash | -25.53%-28.33M | -142.90%-14.01M | -170.42%-22.57M | 3,704.42%32.66M | 63.06%-8.35M | -105.69%-906K | -213.46%-22.6M | 37.79%15.93M | 400.97%19.92M | 237.34%11.56M |
| Begining period cash | -18.02%63.41M | 73.94%77.35M | 73.94%77.35M | -2.16%44.47M | -2.16%44.47M | 51.25%45.45M | 51.25%45.45M | 65.05%30.05M | 21.59%30.05M | -31.95%18.21M |
| Cash at the end | -35.97%35.08M | -18.02%63.41M | 51.64%54.78M | 73.94%77.35M | 58.06%36.12M | -2.16%44.47M | -54.26%22.85M | 51.25%45.45M | 176.12%49.97M | 65.05%30.05M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 51.25%45.45M | ---- | 65.05%30.05M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 51.25%45.45M | ---- | 65.05%30.05M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data